We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+6.31%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.24%
AUM
$13B
AUM Growth
+$1.29B
(+11%)
Cap. Flow
+$656M
Cap. Flow
% of AUM
5.04%
Top 10 Holdings %
Top 10 Hldgs %
16.9%
Holding
287
New
38
Increased
117
Reduced
84
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$85M |
| 2 |
Verizon
VZ
|
+$63.6M |
| 3 |
Boeing
BA
|
+$62.4M |
| 4 |
EOG Resources
EOG
|
+$60.6M |
| 5 |
CME Group
CME
|
+$60M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$124M |
| 2 |
McDonald's
MCD
|
+$102M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$97.9M |
| 4 |
Neurocrine Biosciences
NBIX
|
+$53.7M |
| 5 |
SNI
Scripps Networks Interactive, Inc Common Class A
SNI
|
+$51.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.81% |
| 2 | Healthcare | 18.45% |
| 3 | Industrials | 11.61% |
| 4 | Financials | 11.36% |
| 5 | Consumer Discretionary | 11.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SONC
151
DELISTED
Sonic Corp
SONC
| $28.3M | 0.22% |
1,110,995
+54,605
| +5% | +$1.33M |
|
152
Aclaris Therapeutics
ACRS
$726M
| $28.2M | 0.22% |
1,091,944
-157,310
| -13% | -$4.22M |
|
|
DATA
153
DELISTED
Tableau Software, Inc.
DATA
| $28.1M | 0.22% |
375,891
-61,830
| -14% | -$4.29M |
|
154
Boyd Gaming
BYD
$6.18B
| $28.1M | 0.22% |
1,078,445
-8,755
| -0.8% | -$227K |
|
155
Diamondback Energy
FANG
$57.1B
| $28.1M | 0.22% |
+286,485
| New | +$26.4M |
|
|
IDTI
156
DELISTED
Integrated Device Technology I
IDTI
| $28M | 0.22% |
1,053,795
+5,885
| +0.6% | +$149K |
|
157
Monolithic Power Systems
MPWR
$70.1B
| $27.8M | 0.21% |
261,212
+1,325
| +0.5% | +$135K |
|
158
Middleby
MIDD
$6.04B
| $27.7M | 0.21% |
216,246
-300,134
| -58% | -$37M |
|
159
H.B. Fuller
FUL
$2.97B
| $27.7M | 0.21% |
476,700
+274,433
| +136% | +$14.4M |
|
160
Teledyne Technologies
TDY
$30.4B
| $27.4M | 0.21% |
+172,130
| New | +$25M |
|
161
Dentsply Sirona
XRAY
$2.68B
| $26.8M | 0.21% |
+448,855
| New | +$26.7M |
|
|
ZEN
162
DELISTED
ZENDESK INC
ZEN
| $26M | 0.2% |
894,475
-170,000
| -16% | -$4.77M |
|
163
Expedia Group
EXPE
$35.4B
| $25.9M | 0.2% |
180,239
+43,114
| +31% | +$6.39M |
|
164
PVH
PVH
$4B
| $25.9M | 0.2% |
205,221
-17,260
| -8% | -$2.1M |
|
|
MXIM
165
DELISTED
Maxim Integrated Products
MXIM
| $25.6M | 0.2% |
535,652
+128,110
| +31% | +$5.87M |
|
|
CYBR
166
DELISTED
CyberArk
CYBR
| $25.2M | 0.19% |
614,190
-18,370
| -3% | -$778K |
|
|
ZAYO
167
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $24.7M | 0.19% |
716,929
+107,529
| +18% | +$3.57M |
|
168
BioMarin Pharmaceuticals
BMRN
$11.6B
| $24.6M | 0.19% |
263,925
+152,315
| +136% | +$13.5M |
|
169
DexCom
DXCM
$31.5B
| $24.4M | 0.19% |
1,993,800
-1,656,800
| -45% | -$29.3M |
|
|
170
Neurocrine Biosciences
NBIX
$16.8B
| $23.5M | 0.18% |
383,097
-1,017,488
| -73% | -$53.7M |
|
|
NEWR
171
DELISTED
New Relic, Inc.
NEWR
| $23.2M | 0.18% |
+466,276
| New | +$22M |
|
|
RSPP
172
DELISTED
RSP Permian, Inc.
RSPP
| $23M | 0.18% |
+665,200
| New | +$21.4M |
|
|
BID
173
DELISTED
Sotheby's
BID
| $22.9M | 0.18% |
497,220
-10,500
| -2% | -$518K |
|
174
Bath & Body Works
BBWI
$4.06B
| $22.8M | 0.17% |
+676,366
| New | +$22.7M |
|
|
NVRO
175
DELISTED
NEVRO CORP.
NVRO
| $22.5M | 0.17% |
247,910
-6,230
| -2% | -$533K |
|
Similar funds
OAG
JG
CHP
SAM
Westfield Capital Management's Q3 2017 Portfolio in Review
As of Q3 2017, Westfield Capital Management held 287 positions worth $13B, up 11% from $11.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Westfield Capital Management deployed $656M of net new capital in Q3 2017, opening 38 new positions and adding to 117 existing holdings. Its largest new stake was Bank of America: 3,502,654 shares worth $88.8M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Neurocrine Biosciences, an estimated $53.7M trimmed.
- Westfield Capital Management's largest Q3 2017 buy was Bank of America: 3,502,654 shares worth $88.8M.
- Westfield Capital Management added most to Verizon in Q3 2017, an estimated $63.6M increase.
- Westfield Capital Management's biggest Q3 2017 reduction was Neurocrine Biosciences, cutting an estimated $53.7M.
- Westfield Capital Management fully exited Walt Disney in Q3 2017, selling an estimated $124M.
- Westfield Capital Management's ten largest holdings make up 17% of its $13B portfolio in Q3 2017.
- Westfield Capital Management opened 38 new positions and closed 36 in Q3 2017.
- Westfield Capital Management's portfolio value rose 11% quarter-over-quarter to $13B.
Based on Westfield Capital Management's 13F filing for Q3 2017, filed 13 Nov 2017.